Search

everythinglearnresearchcommunity

for

Search:↓

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

Transgender women can develop feminine traits and improve their quality of life through hormone therapy and surgery, but results vary and access to surgery can be limited.

Aldactone was more effective in reducing hair growth in women with hirsutism than Diane, despite having less impact on hormone levels.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Most women with excessive hair growth have PCOS; treatment varies and focuses on preventing new hair, with electrolysis as the only permanent removal method.

The trial aims to test if spironolactone is an effective acne treatment for women without the side effects of current treatments.

Most women with hirsutism have it because of PCOS, and they need long-term treatment including medication and hair removal to improve their condition.

High levels of anti-Müllerian hormone can indicate polycystic ovarian syndrome in women who can have babies.

Adult female acne is complex and requires a combination of treatments for effective management.

Spironolactone improved symptoms in women with hormonal imbalances and had few side effects.

PCOS is a common hormonal disorder in women, often involving menstrual issues and increased diabetes risk, managed through lifestyle changes and targeted treatments.

Hyperandrogenism is a common hormonal disorder in women, often linked to PCOS.

Infertility requires quick, thorough, and cost-effective evaluation, including medical history, physical exams, and psychological support.

Adding anti-Müllerian hormone to PCOS criteria lowers the number of women diagnosed.

The conclusion is that women under 35 should start fertility checks after 12 months of trying to conceive, women over 35 after 6 months, and women over 40 should start immediately. The checks should include ovulation status, reproductive tract structure, and male partner's semen evaluation.

About 8.5% of women in Salvador, Brazil, have Polycystic Ovary Syndrome.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

Excessive hair growth in women can be harmless or signal serious health issues, and treatment often includes medication and hair removal, with noticeable results after 3-6 months.

Hirsutism in women often indicates a hormonal imbalance and can be managed with a combination of hormonal treatments and hair removal methods.

Hirsutism, excessive hair growth in women, is often caused by PCOS and can be managed with medication and personalized treatment plans.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

The hair lotion reduced hair loss and sped up recovery in women with acute telogen effluvium.

Middle-aged women with PCOS often continue to experience symptoms related to high androgen levels, like unwanted hair growth.

Stem cell treatment improved life quality and sexual function in women with hair loss.

Metformin lowers prolactin in women without PCOS but not in those with PCOS, where it reduces other hormones instead.

PCOS is a hormonal issue in women that is usually treated with birth control pills, metformin, and lifestyle changes, with early treatment helping to reduce complications and improve life quality.

PCOS is a complex disorder in women that can lead to various health risks and requires personalized treatment.

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.

Metformin is effective for treating excessive hair growth in women with PCOS and may work better than the standard treatment in some ways.